Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Clancy

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
JCI Insight|July 13, 2018
Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studiesJohn J Brewington, Erin T Filbrandt, F J LaRosa, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2016
Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysisKevin J Downes, Min Dong, Tsuyoshi Fukuda, et al.
Statistics in Medicine|December 10, 2019
Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progressionRhonda D Szczesniak, Weiji Su, Cole Brokamp, et al.
The Journal of Clinical Investigation|May 31, 2019
Clinically-approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epitheliaDana C Borcherding, Matthew E Siefert, Songbai Lin, et al.
BMC Pulmonary Medicine|June 20, 2020
Data driven decision making to characterize clinical personas of parents of children with cystic fibrosis: a mixed methods studyRhonda D Szczesniak, Teresa Pestian, Leo L Duan, et al.
Pediatric Radiology|August 6, 2016
Feasibility, tolerability and safety of pediatric hyperpolarized <sup>129</sup>Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosisLaura L Walkup, Robert P Thomen, Teckla G Akinyi, et al.
International Journal of Respiratory and Pulmonary Medicine|January 11, 2019
A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseDaniel E Fenker, Cameron T McDaniel, Warunya Panmanee, et al.
The Journal of Biological Chemistry|December 13, 2005
Mutations in the amino terminus of the cystic fibrosis transmembrane conductance regulator enhance endocytosisAsta Jurkuvenaite, Karoly Varga, Krzysztof Nowotarski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 8, 2011
Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activatorsGeorge Pan, Rui Zheng, Pingar Yang, et al.
The Journal of Clinical Investigation|September 5, 2024
Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatmentSarah J Morgan, Ellis Coulter, Hannah L Betts, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
JCI Insight|July 13, 2018
Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studiesJohn J Brewington, Erin T Filbrandt, F J LaRosa, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2016
Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysisKevin J Downes, Min Dong, Tsuyoshi Fukuda, et al.
Statistics in Medicine|December 10, 2019
Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progressionRhonda D Szczesniak, Weiji Su, Cole Brokamp, et al.
The Journal of Clinical Investigation|May 31, 2019
Clinically-approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epitheliaDana C Borcherding, Matthew E Siefert, Songbai Lin, et al.
BMC Pulmonary Medicine|June 20, 2020
Data driven decision making to characterize clinical personas of parents of children with cystic fibrosis: a mixed methods studyRhonda D Szczesniak, Teresa Pestian, Leo L Duan, et al.
Pediatric Radiology|August 6, 2016
Feasibility, tolerability and safety of pediatric hyperpolarized <sup>129</sup>Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosisLaura L Walkup, Robert P Thomen, Teckla G Akinyi, et al.
International Journal of Respiratory and Pulmonary Medicine|January 11, 2019
A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseDaniel E Fenker, Cameron T McDaniel, Warunya Panmanee, et al.
The Journal of Biological Chemistry|December 13, 2005
Mutations in the amino terminus of the cystic fibrosis transmembrane conductance regulator enhance endocytosisAsta Jurkuvenaite, Karoly Varga, Krzysztof Nowotarski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 8, 2011
Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activatorsGeorge Pan, Rui Zheng, Pingar Yang, et al.
The Journal of Clinical Investigation|September 5, 2024
Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatmentSarah J Morgan, Ellis Coulter, Hannah L Betts, et al.
Pageof 13